Is it Worth Adding Systemic Antibiotics to Inhalational Tobramycin Therapy to Treat Pseudomonas Infections in Cystic Fibrosis?

Pseudomonas aeruginosa (PA), a gram-negative rod-shaped bacterium, is one of the most common pathogens causing colonization and infection of the respiratory tract and lungs in patients with cystic fibrosis (CF). Antibiotic therapy is the mainstay treatment for PA infection, and tobramycin is one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Karki, Kumar, Sigdel, Santosh, Kafle, Sunam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451513/
https://www.ncbi.nlm.nih.gov/pubmed/34567873
http://dx.doi.org/10.7759/cureus.17326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451513/
https://www.ncbi.nlm.nih.gov/pubmed/34567873
http://dx.doi.org/10.7759/cureus.17326

Ejemplares similares